Professor Jean-Charles Soria is a Medical Oncologist and Professor of Medicine at Paris-Saclay University. He holds a PhD in molecular biology. He completed his training with a 2-year post-doctoral fellowship at the MD Anderson Cancer Center in Houston, Texas, where in addition he was an associate professor from 2013 to 2017. He was also an elected member of the Oncology Section of the National University Council for 3 years and was the Director of the Gustave-Roussy SIRIC Socrate (Integrated Cancer Research Site) over 5 years (2012-2017).
Since September 2017, Pr. Soria has been Senior Vice-President, Research & Development in Oncology, with AstraZeneca in Gaithersburg, Maryland, USA, where he leads research teams responsible for strategy and for development of new agents in immuno-oncology, cell therapy and conjugated antibodies.
Throughout his career, he has contributed to more than 630 publications in leading international journals and received numerous distinctions. The last prize received is the prestigious ESMO award (European Society for Medical Oncology award) obtained in 2018.